Vicksburg, MS, United States
Kroger Specialty Pharmacy, Inc. recalls
1 recall recorded since 2018, most recently on 3 April 2018. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)0
Terminated or completed1
Class I (FDA)0
Terminated Class II Drugs
- Recall started
- 3 April 2018
- Terminated
- 7 May 2020
- Reason
- Lack of Processing Controls.
- Distribution
- MS, LA, AR, IL, FL
- Initiated
- Voluntary: Firm initiated
- Recall numbers
- D-0796-2018, D-0782-2018, D-0751-2018, D-0766-2018, D-0797-2018, D-0734-2018, D-0741-2018, D-0792-2018, D-0740-2018, D-0743-2018, D-0791-2018, D-0736-2018 and 55 more
- Zarxio 300 mcg/0.5 mL PFS NDC 14 days supply
- Gleevec 100 mg tablet NDC 00078-0401-34 30 days supply
- Orkambi 100 mg/125 mg Tablets #112 NDC 51167-0700-02 28 days supply.
- Copaxone 20 mg Injection PFS (30) NDC 68546-0317-30 30 days supply.
- Tasigna Capsules 150 mg NDC 00078-0592-87 28 days supply
- Humira Pen Sub-q Kit a.) 40 mg/0.8 mL (NDC 00074-4339-02); Humira Pen Psor Kit b.) 40 mg/0.8 mL (NDC 00074-4339-07) 28 day supply, Rx Only,
- Taltz 80 mg/mL Pen 1-pk NDC 00002-1445-11 28 days supply
- Bendeka 25 mg/mL 4 mL MDVPF NDC 63459-0348-04 28 days supply
- and 59 more product lines
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.